autologous bone marrow-derived stem cells (University of Kentucky)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautologous bone marrow-derived stem cells (University of Kentucky)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Kentucky
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Kentucky
Inactive CompaniesN/A
Active IndicationsMyocardial Ischemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A